Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Novus Biologicals™ SP110 Antibody Blocking Peptide
Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition
Supplier: Novus Biologicals™ NBP177316PEP
Description
A blocking peptide containing 15 amino acids near the carboxy terminus of human IPR1. Source: Synthetic (Accession #: NP_004501) The SP110 Blocking Peptide has been validated for the following applications: Antibody Competition.Specifications
3431 | |
Store at -20 C. Avoid freeze-thaw cycles. | |
This Peptide is Useful as a Blocking Peptide for NBP1-77316. For Further Blocking Peptide Related Protocol, Click Here . | |
SP110 | |
0.05 mg | |
Synthetic |
Human | |
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin. | |
FLJ22835, IFI41, IFI75, interferon-induced protein 41, 30 kD, Interferon-induced protein 41/75, interferon-induced protein 75, 52 kD, IPR1, phosphoprotein 41, phosphoprotein 75, SP110 nuclear body protein, Speckled 110 kDa, Transcriptional coactivator Sp110, VODI | |
SP110 | |
RUO - research use only | |
15 amino acids near the carboxy terminus of human IPR1 |
Provide Content Correction
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?
Provide Content Correction